Dr. Thierry Alcindor, MD, MSc, FRCPC
Director of Medical Oncology
McGill University Health Centre (MUHC)
Associate Director for Oncology Clinical Trials
Center for Innovative Medicine, MUHC
Associate Professor of Oncology and Medicine
McGill University
Montreal, Quebec

Dr. Thierry Alcindor was born and raised in Port-au-Prince, Haiti. After obtaining his medical degree at Université d’État d’Haïti, he trained in Internal Medicine and Hematology/Oncology at Yale-New Haven Medical Center and Tufts-New England Medical Center, respectively, in the USA. He also holds a Master’s degree in Experimental Therapeutics from the University of Oxford (UK.)

Currently as Associate Professor of Oncology and Medicine at McGill University, and Associate Director for Clinical Trials in Oncology at the Center for Innovative Medicine, McGill University Health Centre in Montreal (Canada), he focuses his clinical and research efforts on the care of patients with digestive cancers and sarcomas.

Dr. Alcindor’s clinical research portfolio includes investigator-initiated studies, as well as trials with pharmaceutical companies and oncology cooperative groups. He is co-chair of the Sarcoma Disease Site Committee of the Canadian Cancer Trials Group (CCTG) and a key member of its Gastrointestinal Disease Site Committee as well. In both capacities, he has led several studies as a national principal investigator in Canada. He has authored or co-authored more than 80 peer-reviewed papers, abstracts and book chapters in his areas of expertise.

Dr. Paul Clarkson
Orthopaedic Oncology Surgeon, BC Cancer Agency
Vancouver, BC

Dr Paul Clarkson is a Orthopaedic Oncology Surgeon in Vancouver, Canada. Having completed surgical training in Perth, Australia he undertook Fellowship training in Musculoskeletal Oncology in Toronto and Vancouver. He completed a Masters Degree focussed on molecular biology of osteosarcoma. On staff in Vancouver since 2006, his clinical practice focusses on the surgical management of bone and soft tissue tumours. A firm believer in multi-disciplinary assessment and management of these tumours, he is an intergral part of the bone and soft tissue tumour group at the BC Cancer Agency and the BC Children’s Hospital. Non-clinical Interests include education and clinical outcomes research.

Lee D Cranmer MD, PhD
Associate Professor of Medicine
, University of Washington
Associate Member
, Fred Hutchinson Cancer Research Center
Seattle, WA

Lee D Cranmer MD, PhD is an Associate Professor of Medicine at the University of Washington and Associate Member of the Fred Hutchinson Cancer Research Center in Seattle, Washington, USA. After graduating from the University of California San Diego with his medical degree and doctoral degree in viral immunology, Dr. Cranmer completed residency training in internal medicine at the Mayo Clinic and fellowship training in medical oncology at the University of Arizona. He remained at the University of Arizona as a faculty member until 2015, at which time he moved to Seattle for his present position. His professional interests include all aspects of sarcoma management. He is also interested in cancer immunotherapy, clinical trial design, management of cutaneous malignancies, cancers of unknown primary origin and management of brain metastases.

Dr. Karen Goddard, MD MRCP (UK) FRCP(C) MA
Medical Director of the Adult Childhood Cancer Survivorship Program
Chair Sarcoma Tumor Group
Clinical Professor, UBC
Radiation Oncology
BC Cancer Agency
Vancouver  BC

Karen Goddard is a clinical professor (University of British Columbia) and a radiation oncologist (BC Cancer Agency). She is currently the medical director of the Adult Childhood Cancer Survivorship Program and the Chair of the Provincial Sarcoma Tumor Group. Her special clinical interests include pediatric radiation oncology, the management of soft tissue and bone sarcomas, pediatric oncology medical education and survivorship/long-term health problems in adults after treatment for childhood cancer.  She also has expertise in the field of Canadian Health Law and graduated in 2014 with an interdisciplinary degree in Law and Medicine from the University of British Columbia.

Kyle Grant, MD, MHSc, FRCSC
Clinical Instructor, Division of Thoracic Surgery University of British Columbia Vancouver, BC

Dr. Kyle Grant is a Thoracic Surgeon at Vancouver General Hospital.  He completed his medical school training and General Surgery residency at the University of Manitoba.  He subsequently completed his Thoracic Surgery Fellowship at the University of British Columbia and also holds a Masters Degree from the School of Population and Public Health at UBC.  His interests are Thoracic Oncology and Minimally Invasive Thoracic Surgery.

Abha Gupta, MD, MSc, FRCPC
Associate Professor, Department of Pediatrics, University of Toronto
Staff Oncologist, Solid Tumour Program, Hospital for Sick Children
Staff Oncologist, Sarcoma Program, Princess Margaret Cancer Centre
Medical Director, Adolescent and Young Adult Program, PM
Toronto, ON

Dr. Abha Gupta received her MD at the University of Toronto.  She completed her pediatrics residency at Yale New Haven Children’s Hospital (New Haven, CT) and Children’s Hospital of Eastern Ontario (Ottawa) before moving back to Toronto to complete her fellowship in paediatric hematology/oncology at The Hospital for Sick Children.  To complement her training, Dr. Gupta completed a one-year fellowship in Adolescent and Young Adult Oncology with a focus on sarcoma at Princess Margaret.  She is currently cross appointed as a staff oncologist at both The Hospital for Sick Children and Princess Margaret Cancer Center.

Dr. Gupta’s primary clinical and research interests include sarcoma, adolescent and young adult oncology, and oncofertility.

She is the Medical Director of the Adolescent and Young Adult Oncology Program at Princess Margaret and an executive member of the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.

Douglas S. Hawkins, MD
Professor of Pediatrics
University of Washington School of Medicine
Div.Chief of Hematology/Oncology
Associate Director
Center for Clinical & Translational Research
Seattle Children’s Hospital
Seattle, WA

Douglas S. Hawkins, MD, is the Hematology/Oncology Division Chief, Associate Director of the Center for Clinical and Translational Research at Seattle Children’s Hospital (SCH), clinician at SCH, and Professor of Pediatrics at the University of Washington School of Medicine. Dr. Hawkins is a leader in the Children’s Oncology Group (COG). He is the Chair of the Soft Tissue Sarcoma Committee, which oversees the conduct of biology studies and clinical trials for rhabdomyosarcoma and other soft tissue sarcomas across North America. He is a member of the COG Bone Tumor Steering Committee. He is also the Chair of the COG Scientific and Discipline Chairs Committee. Dr. Hawkins has focused on clinical research, particularly in the treatment of pediatric sarcomas. He has been the chair of two COG clinical trials, one for Ewing sarcoma and another for rhabdomyosarcoma. He chairs the international EURO EWING Consortium External Advisory Board.

Dr. Caroline Holloway, MD FRCPC
Clinical Assistant Professor
Radiation Oncologist
BC Cancer Agency, Vancouver Island Centre
Victoria, British Columbia

Dr. Caroline Holloway is a Radiation Oncologist at the BCCA – Vancouver Island Centre with a special interest in Sarcoma, lymphoma and gynecologic malignancies.  She trained at the Cross Cancer Institute in Edmonton followed by a fellowship at Harvard University in Boston.  Dr. Holloway is the current radiation oncology lead for the Sarcoma tumour group.

Andrea Johnson, 
 School of Social Work
University of British Columbia
Vancouver, BC

Andrea Johnson is a PhD Candidate in the School of Social Work at the University of British Columbia. She is also a clinical social worker at Canuck Place Children’s Hospice in Vancouver, B.C. She has extensive practice and research experience involving adolescents and young adults throughout the cancer trajectory

Robin Jones, MD, MRCP
Team Leader, Sarcoma Clinical Trials,
The Institute of Cancer Research
Consultant Medical Oncologist
The Royal Marsden,
London, England

Robin Jones is a medical oncologist with a specialist interest in bone and soft issue sarcomas. He has been principle investigator on numerous phase I, II and III trials.

He completed his medical training at Guy’s and St Thomas’ Hospital, and his oncology training at The Royal Marsden. His postgraduate research degree, with Professor Dowsett at the ICR, evaluated potential predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy.

In January 2010 he was appointed Associate Professor and Director of the Sarcoma Program at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle. He led a successful clinical and research program and continued his translational and trial-based research. The laboratory work with Dr Seth Pollack evaluated novel immunotherapeutic targets in bone and soft tissue sarcomas, and has led to a number of early-phase immunotherapeutic clinical trials.

He is Consultant Medical Oncologist and Reader at the Royal Marsden and ICR. He is currently working on a number of trials of investigational agents in sarcomas as well as laboratory-based studies with Dr Paul Huang.

He is a member of the Sarcoma Alliance for Research through Collaboration (SARC) concept review committee, European Organization for Research and Treatment of Cancer (EORTC) Sarcoma Group, the American Joint Committee on Cancer (AJCC) soft tissue sarcoma staging panel. He has previously served on the American Society of Clinical Oncology (ASCO) Educational Committee and the National Comprehensive Cancer Network (NCCN) Bone Tumour Panel.

David Liu, MD, FRCP(C), FSIR, ABR(D), CAQ(IR)
Clinical Professor
University of British Columbia
Vancouver, BC

Dr David M Liu MD is an Interventional Radiologist with the current appointments of Clinical Professor of Radiology at the University of British. He is board certified in both Canada and the US, and holds appointments at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the department of Surgery. Dr Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, and interventional radiology fellowship at Northwestern Memorial Hospital, and has practiced on both sides of the border. In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease. Dr Liu maintains an active clinical practice interventional oncology practice incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems. He is the co-founder and co-chair of SHOW, and has been credited with 6 book chapters, over 50 publications, over 100 invited lecture worldwide, and is an active member and inducted fellow of the Society of Interventional Radiology. He had recently been awarded the CIRA award from the Canadian Association of Interventional Radiology (CAIR), in recognition of his extraordinary contribution to the practice of IR in Canada and worldwide. He holds specific interest in the treatment of hepatocellular carcinoma, and metastatic colorectal carcinoma and is actively involved in both translational research and clinical trials.

Mitchell C.C. Liu, MDCM, FRCPC
Clinical Associate Professor
Radiation Oncology
BC Cancer – Vancouver
Vancouver, BC

Dr. Liu completed his radiation oncology residency at McGill University and a radiation oncology
fellowship at Massachusetts General Hospital in Boston. He is currently in the Lung and GI team and has been one of the leaders in SABR treatments of lung, liver, spine and oligometastases at BC Cancer.

Dr. Andrea MacNeill, MD, FRCSC
Surgical Oncologist
Vancouver General Hospital, BCCA
Clinical Assistant Professor
University of British Columbia
Vancouver, BC

Dr. MacNeill is a surgical oncologist at Vancouver General Hospital and the BC Cancer Agency, and a clinical assistant professor at the University of British Columbia.  She completed General Surgery residency at the University of British Columbia followed by fellowship training in Surgical Oncology at the University of Toronto, the Istituto Nazionale dei Tumori in Milan, Italy and the Royal Marsden Hospital in London, UK.  She is the provincial education coordinator for the BCCA Sarcoma Tumour Group and a founding member of the BCCA Sarcoma Outcomes Unit and the Canadian Abdominal Sarcoma Collaborative.  She completed a Master’s of Environmental Change and Management at the University of Oxford and has research interests in sustainable health care as well as clinical outcomes of retroperitoneal and abdominal sarcoma.

Dr. Tony Ng, MD, PhD, FRCPC
Clinical Assistant Professor, Pathology and Laboratory Medicine,
University of British Columbia
Consultant Head and Neck Pathologist, Vancouver General Hospital
Vancouver, BC

Dr. Tony Ng is a consultant pathologist at the Vancouver General Hospital and the British Columbia Cancer Agency, with a subspecialty practice in sarcoma pathology and head and neck pathology. He is also a clinical assistant professor at the University of British Columbia, and the Anatomical Pathology residency program site director at the Vancouver General Hospital. Dr. Ng received his MD and completed his Anatomical Pathology residency at the University of British Columbia, with subsequent surgical pathology fellowship training at Stanford University. He also concurrently completed his PhD in molecular oncology and cell biology in Dr. Poul Sorensen’s laboratory at the BC Cancer Research Center. His research interests are in cancer genomics, particularly in relation to molecular diagnostics for fusion gene-associated cancers such as sarcomas, and the incorporation of next-generation genomic findings into surgical pathology practice.

Torsten O. Nielsen, MD/PhD FRCPC
Professor of Pathology and Laboratory Medicine
Associate Member, Department of Orthopaedics
University of British Columbia
Chair, Sarcoma Disease Site Committee
Canadian Cancer Trials Group
Vancouver, BC

Torsten O. Nielsen is a Professor of Pathology and Laboratory Medicine at the University of British Columbia. After completing the combined MD/PhD program at McGill, he undertook training at UBC, ICRF London, Stanford, the Cleveland Clinic and the Royal Orthopaedic before taking a position as a clinician-scientist pathologist, specializing in sarcomas. His contributions have included the world’s first large scale microarray studies of sarcomas, development of the DOG-1, TLE and beta-catenin biomarkers and of NanoString technology for clinical diagnostics, identification of the biology driving tenosynovial giant cell tumors, synovial sarcoma and epithelioid sarcoma, and involvement in clinical trials of targeted therapies for these tumor types. Currently, Dr. Nielsen is leading the International Rare Cancers Initiative for synovial sarcoma, and is Director of the MD/PhD program at UBC.

David Perrin, MD, FRCSC
Clinical Fellow, Orthopaedic Oncology
BC Cancer
University of British Columbia
Vancouver, BC

Dr. David Perrin is currently a Clinical Fellow in Orthopaedic Oncology at the University of British Columbia. He received his MD at the Université de Sherbrooke and completed his residency in Orthopaedic Surgery at the University of Manitoba. Dr. Perrin completed fellowship training in Musculoskeletal Oncology at the University of Toronto prior to this year. He has recently presented his research endeavors at the Musculoskeletal Tumor Society and the Connective Tissue Oncology Society annual meetings. He will be starting the first Musculoskeletal Oncology program in his home province of Manitoba in the summer of 2019 through Cancer Care Manitoba.

Seth Pollack, MD
Assistant Professor, Division of Oncology
University of Washington School of Medicine
Attending Medical Oncologist
Seattle Cancer Care Alliance
Seattle, WA

Dr. Pollack is an attending oncologist specializing in sarcoma at the Seattle Cancer Care Alliance (SCCA; a partnership between the UW, FHCRC and Seattle Children’s Hospital), the largest tertiary referral center for sarcoma in the Northwest. Dr. Pollack’s research focus has been the development of novel immunotherapies for sarcoma with a particular focus on Synovial Sarcoma and Myxoid/Round Cell Liposarcoma. He has been featured in the widely followed audio/cd/podcast series Research-to-Practice and wrote the invited review for the Journal of Clinical Oncology on immunotherapies and other novel therapies in sarcoma. He has received awards supporting his research from the V Foundation  and the Alliance for Cancer Gene Therapy. He received the Sig Kohl Legacy award from the Northwest Sarcoma Foundation for an “outstanding and enduring contribution to the care of sarcoma patients in the Northwest.”

Dr. Shannon K.T. Puloski, MD, FRCS(C)
Associate Professor
University of Calgary
Orthopaedic Surgeon
Foothills Medical Centre
Calgary, AB

Dr. Puloski is an Orthopaedic Surgeon specializing in MSK Oncology & Joint Reconstruction.  He is an Associate Professor at the University of Calgary and has provided sarcoma care for patients at the Foothills Medical Centre, Alberta Children’s Hospital & Tom Baker Cancer since 2006.

He completed his medical school at the University of Western Ontario, and surgical residency at the University of Calgary.  He obtained subspecialty fellowship training in Bern, Switzerland, Oxford, England and at the University of Toronto.

He is currently the Division Head for Orthopaedic Oncology in the Section of Orthopaedics at the University of Calgary and the Provincial Sarcoma Group Leader for Cancer Care Alberta.

Current research and academic interests include improving outcomes in patients with soft tissue sarcomas and improved surgical decision making in patients with metastatic bone disease.

Jason Rockhill, M.D., Ph.D.
Associate Professor, Departs of Radiation Oncology & Neurological Surgery
University of Washington
Seattle, WA

Jason Rockhill, M.D., Ph.D. is an Associate Professor in the Departments of Radiation Oncology and Neurological Surgery at the University of Washington. He is Clinical Co-Director of the Alvord Brain Tumor Center and the UW Medicine Gamma Knife Center. His practice and research focus on CNS malignancies and the various forms of radiation for treatment.

Dr. Harold (Hal) Siden, MD, MHSc, FRCPC
Clinical Professor, Division of General Pediatrics, Department of Pediatrics
Faculty of Medicine, University of British Columbia
Investigator, BC Children’s Hospital
Medical Director, Canuck Place Children’s Hospice
Vancouver, BC

Dr. Harold (Hal) Siden, MD, MHSc, FRCPC is Medical Director at Canuck Place Children’s Hospice in Vancouver, Canada. He is also is an Attending Physician in Pediatrics and Medical Director of Palliative Medicine at BC Children’s Hospital and an Investigator in the BCCH Research Institute. He is a Clinical Professor in the Department of Pediatrics at the University of British Columbia (UBC). His clinical interests are pediatric palliative care, pediatric pain management and general & complex care pediatrics. He is Principal Investigator on several projects funded by the Canadian Institutes for Health Research.

Dr. Christine Simmons, MD, MSc, FRCPC
Medical Oncologist, BCCA Vancouver
Clinical Associate Professor
Department of Medicine
University of British Columbia
Vancouver, British Columbia

Dr. Christine Simmons is a Medical Oncologist at the BCCA Vancouver and Clinical Associate Professor in the Department of Medicine at the University of British Columbia.   She completed her residency training in Toronto, and completed a fellowship at Princess Margaret Hospital in Toronto.  She also completed a Master’s in Clinical Epidemiology at University of Toronto.  She is currently the Chair of Sarcoma Systemic Program for BCCA.  She is the former chair of the Locally Advanced Breast Cancer National Consensus group and still plays a key role in that organisation.  Her academic interests span both teaching and research, and she has held several leadership roles in the Undergraduate Medical Program at UBC in the areas of clinical skills and oncology education.  Her research interests are in the areas of health services research in breast cancer and sarcoma.  She recently founded the Sarcoma Outcomes Unit at the BC Cancer Agency, and is Founder and Chair of the not‑for‑profit organisation, Women in Cancer.

Alannah Smrke MD, FRCPC
Medical Oncology Resident, PGY5
BC Cancer
Vancouver, BC

Alannah Smrke is the co-chief medical oncology resident at BC Cancer. She completed her MD and Internal Medicine Residency at McMaster University in Hamilton, Ontario. She has an interest in sarcoma, adolescent and young adult oncology and medical education.

Poul Sorensen, MD, PhD
Anatomic Pathologist
Professor of Pathology & Laboratory
University of British Columbia
Vancouver, BC

Dr. Poul Sorensen is a board certified anatomic pathologist, specializing in the molecular pathology of pediatric cancers. He undertook his undergraduate, medical, and PhD degrees at the University of British Columbia (UBC) and McGill University, Montreal. He completed postdoctoral training at the University of Minnesota, Minneapolis and Children’s Hospital Los Angeles, University of Southern California, after his Pathology training. He then returned to Vancouver to start his own laboratory at Children’s and Women’s Hospital in Vancouver. Dr. Sorensen holds the Asa and Kashmir Johal Endowed Chair in Childhood Cancer Research, and he is Professor of Pathology and Laboratory Medicine at UBC, as well an Honorary Professor at University College London, UK. Dr. Sorensen’s research laboratory is located in the Department of Molecular Oncology at the BC Cancer Research Centre, where he is a senior scientist. His research focuses on targeting aberrant signaling pathways that are activated in childhood cancers and breast carcinoma. Dr. Sorensen’s laboratory uses a combination of genetic and biochemical approaches to identify proteins that are specifically altered in human tumours. His laboratory has discovered many novel genetic alterations in childhood cancer and breast tumours, and these discoveries have been translated into new diagnostic tests for specific tumours, and have advanced our understanding of how the involved proteins transmit signals that cause cells to become cancerous. Such information then allows for the rapid implementation of strategies to target these proteins therapeutically. Dr. Sorensen is the Chair of the Translational Research Committee of the Children’s Oncology Group (COG), the largest pediatric oncology clinical trials network in the world.

Amirrtha Srikanthan, MD, MHSc, FRCPC, CHE
Assistant Professor of Medicine, University of Ottawa
Medical Oncology, The Ottawa Hospital Cancer Centre
Clinical Investigator, The Ottawa Hospital Research Institute
Ottawa, ON

Dr. Amirrtha Srikanthan is an Assistant Professor of Medicine at the University of Ottawa, Clinician Investigator with the Ottawa Hospital Research Institute, and Medical Oncologist at The Ottawa Hospital Cancer Centre. An adult medical oncologist by training, she completed fellowship training at the Princess Margaret Cancer Centre in Toronto, Canada, in AYA Oncology. During her appointment at BC Cancer in Vancouver, Canada, she served as Medical Lead for the development of a provincial AYA program.  In Ottawa, she continues with regional AYA program development and treats sarcoma and breast patients. She currently serves as Chair of the National Royal College Focused Competency Diploma in AYA Oncology.

Winan van Houdt
Surgical Oncologist
The Netherland Cancer Institute/Antoni van Leeuwenhoek Hospital
Amsterdam, NL

Winan van Houdt is a sarcoma surgeon and surgical oncologist at The Netherland Cancer Institute/Antoni van Leeuwenhoek hospital in Amsterdam, the Netherlands. Previously, he did an international fellowship focusing on sarcoma in Toronto and Milan and also worked as a sarcoma surgeon in the Royal Marsden Hospital, London.

He has a special interest in surgery for limb and trunk, retroperitoneal and intra-abdominal sarcoma. He is involved in several (international) research projects for sarcoma en desmoid tumors.

He is a member of the Transatlantic RPS Working Group and part of the board of the Connective Tissue Oncology Society and the Soft Tissue and Bone Sarcoma Group, EORTC as a young oncologist.

Michael J. Wagner, M.D.
Assistant Professor, University of Washington, Division of Medical Oncology
Assistant Member, Fred Hutchinson Cancer Research Center, Clinical Research Division
Seattle, WA

Michael J. Wagner, MD is an Assistant Professor of Medicine at the University of Washington and an Assistant Member in the Clinical Research Division at the Fred Hutchinson Cancer Research Center (FHCRC). After graduating from Harvard University with a medical degree, Dr. Wagner completed his residency at Mt. Sinai Hospital in New York and medical oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Wagner has received numerous awards, including the Conquer Cancer Foundation of ASCO Young Investigator Award and QuadW Foundation-AACR Fellowship for Clinical/Translational Research for his research on sarcoma. Dr. Wagner has been in his current position since 2017. His professional interests include angiosarcoma and other vascular sarcomas, and bone and soft tissue sarcoma.

Lorna Weir, MD, FRCPC
Radiation Oncologist, BC Cancer
Head of the Department, Radiation Oncology
Vancouver, BC

Dr. Lorna Weir is a Radiation Oncologist at BC Cancer – Vancouver where she is Head of the Department of Radiation Oncology .

She is a Clinical Professor in the UBC Faculty of Medicine been a member of the Sarcoma Tumour Group since 1997.

Her main clinical area is Musculoskeletal tumours.

Paul Willinsky, BSc, BTech
Radiation Therapist
BC Cancer Vancouver Center
Vancouver, BC

Paul has been a radiation therapist for 10 years, working in Vancouver, Kelowna, and Switzerland.  He is currently working in the planning module on the CT simulator. Since 2012, Paul has been involved as a champion in BC’s Patient Reported Outcomes program: The Prospective Outcomes and Support Initiative (POSI).  In recent years, he has taken a team lead role in the program – helping Vancouver center sustain and expand the POSI program. Paul is also a member of the imaging committee, journal review, and the radiation department social committee. Outside of work, Paul can be found running races and visiting Vancouver’s diverse craft brewery scene.

Don Wilson, BSc (Hon), MD, FRCPC (Nuc Med), FRCPC (Rad Onc)
Nuclear Medicine Physician
Radiation Oncologist
BC Cancer
Vancouver, BC

Dr. Wilson is a Nuclear Medicine Physician and Radiation Oncologist at BC Cancer where he has served as Medical Director of the Functional Imaging Program since 2005. In this role Don has overseen implementation of the province’s first Positron Emission Tomography/Computerized Tomography (PET/CT) scanner at BC Cancer’s Vancouver Centre. Under his medical leadership the Functional Imaging Program has expanded to include two state of the art PET/CT scanners, a cyclotron facility as well as clinical and research radiopharmaceutical laboratories. In addition to providing diagnostic imaging services for oncology patients across BC, the Program includes leading clinical, preclinical and scientific research components with local, national and international academic collaborations.

Don graduated from the University of Saskatchewan in 1989 with degrees in Biochemistry and Medicine. He did post-graduate training in Internal Medicine at the University of British Columbia and went on to complete specialty training in Nuclear Medicine at the University of Western Ontario, Radiation Oncology at the University of British Columbia, and a Fellowship in PET imaging and radiobiology at the University of Washington Medical Center in Seattle.

Don joined the BC Cancer Agency as a staff Radiation Oncologist in 1998. He is currently Provincial Lead for Functional Imaging at BC Cancer and actively involved in clinical teaching at the undergraduate, post-graduate and fellowship levels.